SOLAR: Efficacy and Safety of Cobomarsen (MRG-106) vs. Active Comparator in Subjects With Mycosis Fungoides
Condition: Cutaneous T-Cell Lymphoma/Mycosis Fungoides Interventions: Drug: Cobomarsen; Drug: Vorinostat Sponsor: miRagen Therapeutics, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials